Alniche Lifesciences forays into cardio-diabetic area
29 September 2021 | News
Introduction of value-added products to take care of vital organs of circulatory system
Image Credit: Shutterstock
Alniche Lifesciences is planning to expand into a new therapy area i.e. cardio-diabetic. This includes the introduction of value-added products to take care of vital organs of the circulatory system that is severely affected due to the COVID-19 pandemic.
Girish Arora, Founder & MD - Alniche Lifesciences said, "The company intends to broaden its reach through exports, since Indian pharmaceutical products possess a high reputation in other countries, putting India among the top five pharmaceutical exporters in the world.’’
